TY  - GEN
AU  - Klisovic,Rebecca B
AU  - Blum,William
AU  - Liu,Zhongfa
AU  - Xie,Zhiliang
AU  - Kefauver,Cheryl
AU  - Huynh,Lenguyen
AU  - Zwiebel,James A
AU  - Devine,Steven M
AU  - Byrd,John C
AU  - Grever,Michael R
AU  - Chan,Kenneth K
AU  - Marcucci,Guido
TI  - Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia
SN  - 1029-2403
PY  - 2015///0715
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Cytarabine
KW  - Female
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Oligodeoxyribonucleotides
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.3109/10428194.2013.838764
ER  -